Dewailly D, Andersen CY, Balen A, Broekmans F, Dilaver N, Fanchin R, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20:370–85.Web of SciencePubMedCrossrefGoogle Scholar
Broer SL, Broekmans FJ, Laven JS, Fauser BC. Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications. Hum Reprod Update 2014;20:688–701.CrossrefPubMedWeb of ScienceGoogle Scholar
Iliodromiti S, Anderson RA, Nelson SM. Technical and performance characteristics of anti-Mullerian hormone and antral follicle count as biomarkers of ovarian response. Hum Reprod Update 2015;21:698–710.CrossrefPubMedWeb of ScienceGoogle Scholar
Fleming R, Fairbairn C, Gaudoin M. Objective multicentre performance of the automated assays for AMH and estimation of established critical concentrations. Hum Fertil (Camb) 2017;8:1–5.Google Scholar
Li HW, Wong BP, Ip WK, Yeung WS, Ho PC, Ng EH. Comparative evaluation of three new commercial immunoassays for anti-Mullerian hormone measurement. Hum Reprod 2016;31:2796–802.PubMedCrossrefWeb of ScienceGoogle Scholar
Demirdjian G, Bord S, Lejeune C, Masica R, Riviere D, Nicouleau L, et al. Performance characteristics of the Access AMH assay for the quantitative determination of anti-Mullerian hormone (AMH) levels on the Access* family of automated immunoassay systems. Clin Biochem 2016;49:1267–73.Web of ScienceCrossrefPubMedGoogle Scholar
Whiting G, Ferguson J, Fang M, Pepin D, Donahoe P, Matejtschuk P, et al. Quantification of Mullerian inhibiting substance/anti-Mullerian hormone polypeptide by isotope dilution mass spectrometry. Anal Biochem 2018;6. pii: S0003-2697(18)30222-7. DOI: 10.1016/j.ab.2018.05.006. [Epub ahead of print].Web of ScienceGoogle Scholar
About the article
Published Online: 2018-07-18
Published in Print: 2018-12-19
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This work was supported by the Research Funds for Jiangsu Province Key Research and Development Plan (grant number BE2016750) and Jiangsu province key medical talents (grant number ZDRCA2016096) and the Research Funds for Military Family Planning (grant number 16JS012) to B. Yao. The Research Funds for Nanjing Jinling Hospital (grant number 2016041) to J. Jing.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.